Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: CEO and Chairman of $PATH Sells 45,000 Shares

Automated

Daniel Dines, the CEO and Chairman of $PATH, sold 45,000 shares of the company on 12-16-2025 for an estimated $731,515. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.2% of their shares of this class of stock. Following this trade, they now own 28,928,585 shares of this class of $PATH stock.

$PATH Insider Trading Activity

PATH Insider Trades

$PATH insiders have traded $PATH stock on the open market 91 times in the past 6 months. Of those trades, 0 have been purchases and 91 have been sales.

Here’s a breakdown of recent trading of $PATH stock by insiders over the last 6 months:

  • DANIEL DINES (CEO and Chairman) has made 0 purchases and 75 sales selling 5,050,121 shares for an estimated $71,467,078.
  • ASHIM GUPTA (COO & CFO) has made 0 purchases and 4 sales selling 297,196 shares for an estimated $4,878,547.
  • BRAD BRUBAKER (GC & Chief Legal Officer) has made 0 purchases and 4 sales selling 137,908 shares for an estimated $2,212,907.
  • HITESH RAMANI (Chief Accounting Officer) has made 0 purchases and 8 sales selling 65,000 shares for an estimated $1,057,210.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$PATH Hedge Fund Activity

We have seen 243 institutional investors add shares of $PATH stock to their portfolio, and 301 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$PATH Revenue

PATH Quarterly Revenue

$PATH had revenues of $411.1M in Q3 2026. This is an increase of 15.92% from the same period in the prior year.

You can track PATH financials on Quiver Quantitative's PATH stock page.

$PATH Analyst Ratings

Wall Street analysts have issued reports on $PATH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Canaccord Genuity issued a "Buy" rating on 09/08/2025

To track analyst ratings and price targets for $PATH, check out Quiver Quantitative's $PATH forecast page.

$PATH Price Targets

Multiple analysts have issued price targets for $PATH recently. We have seen 11 analysts offer price targets for $PATH in the last 6 months, with a median target of $17.0.

Here are some recent targets:

  • Matthew Hedberg from RBC Capital set a target price of $19.0 on 12/10/2025
  • Sanjit Singh from Morgan Stanley set a target price of $19.0 on 12/09/2025
  • Lucky Schreiner from DA Davidson set a target price of $15.0 on 12/05/2025
  • Kingsley Crane from Canaccord Genuity set a target price of $19.0 on 12/04/2025
  • Michael Turrin from Wells Fargo set a target price of $14.0 on 12/04/2025
  • Raimo Lenschow from Barclays set a target price of $16.0 on 12/04/2025
  • Siti Panigrahi from Mizuho set a target price of $15.0 on 12/04/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles